Last updated on November 2017

Proteinuria in kidney disease and diabetes


Brief description of study

Proteinuria in kidney disease and diabetes

Detailed Study Description

The purpose of the study is to evaluate whether or not atrasentan is effective in delaying the worsening of kidney disease by comparing the time to serum creatinine doubling or the onset of end stage renal disease in patients with Type 2 diabetes and kidney disease.

Clinical Study Identifier: TX7561

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Stephanie Hanzl

Northeast Clinical Research Center, LLC.
Bethlehem, PA USA
  Connect »